APA aipamena

Egaña, L., Auzmendi-Iriarte, J., Andermatten, J., Villanua, J., Ruiz, I., Elua-Pinin, A., . . . Samprón, N. (2020). Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital. Sci Rep.

Chicago Style aipamena

Egaña, Larraitz, et al. "Methylation of MGMT Promoter Does Not Predict Response to Temozolomide in Patients With Glioblastoma in Donostia Hospital." Sci Rep 2020.

MLA aipamena

Egaña, Larraitz, et al. "Methylation of MGMT Promoter Does Not Predict Response to Temozolomide in Patients With Glioblastoma in Donostia Hospital." Sci Rep 2020.